ResMed rising as Cochlear faces pressure

The two medical device manufacturers are on divergent paths.

Once both market darlings, ResMed (RMD) and Cochlear (COH) appear to be on divergent performance paths.

ResMed shares soared late last week after the sleep and breathing disorder device manufacturer unveiled an 11% lift in fourth-quarter revenue despite challenging market conditions.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles